Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
US11903948B2 · kind B2 · utility
0Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2021 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Mar 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a preparation method of an antibody-drug conjugate represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof, or a solvate of the foregoing,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.